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ABSTRACT
Background and aims: Gut microbiota (GM) has been involved in the pathophysiology of
hypertension (HT), notably via short chain fatty acids (SCFAs). Among the clinical manifestations
of HT, the absence of a significant drop in night-time blood pressure (BP) (also known as the
non-dipping BP profile) has been associated with poor renal and cardiovascular outcomes. The
putative link between GM-derived metabolites and BP dipping status is still unknown.
Methods: Male volunteers (n¼ 44) were prospectively subjected to 24-hour ambulatory blood
pressure monitoring, stool sample collection and a medical questionnaire. Metabolomics analy-
ses of stool samples were conducted using Nuclear Magnetic Resonance (NMR).
Results: Higher amounts of acetate, butyrate and propionate were found in the stools of non-
dippers (n¼ 12) versus dippers (n¼ 26) (p¼ 0.0252, p¼ 0.0468, and p¼ 0.0496, respectively;
n¼ 38 in toto). NMR spectral data were not interpretable in 5 dippers and 1 non-dipper. A simi-
lar significant association was found when including only patients without anti-HT medications
(p¼ 0.0414, p¼ 0.0108, and p¼ 0.0602, respectively; n¼ 21 in toto). A not significant trend was
observed when focussing only on HT patients without anti-HT medications (p¼ 0.0556; n¼ 14
in toto).
Conclusion: Our pilot study highlights a putative link between GM-derived SCFAs and the BP
dipping status, independently of the BP status itself or the anti-hypertensive medications.
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Gut microbiota (GM) has been involved in the patho-
physiology of hypertension (HT), possibly via its role in
the production of short chain fatty acids (SCFAs) from
diet carbohydrate fermentation [1]. We and others
have recently reported on significant correlations
between the 24h mean blood pressure (BP) levels and
the entire stool metabolome, as well as between BP
levels and the faecal abundance of bacteria belonging
to the Clostridial order. Higher amounts of the 3 main
SCFAs (i.e. acetate, butyrate and propionate) have
been also found in the stools of patients with HT com-
pared to normotensive (NT) controls [2,3]. The absence
of a significant drop in night-time BP (also known as
the non-dipping BP profile) measured by 24-hour
ambulatory BP monitoring (24h-ABPM) has been asso-
ciated with poor renal and cardiovascular outcomes,
independently of HT [4]. In our previous study, no sig-
nificant difference in GM composition was observed
between dippers versus non-dippers [2]. However, we
did not compare the faecal metabolome of dippers
versus non-dippers. So, the putative link between GM-
derived metabolites and BP dipping status
remains unknown.
Methods
We investigated a cohort of male volunteers who
were prospectively recruited and subjected to 24h-
ABPM, stool sample collection and a medical question-
naire. A patient was categorised as non-dipper if the
ratio between night and day systolic BP was >0.9. The
patients were categorised in two groups, i.e. NT or HT,
on the basis of the European Society of Hypertension
criteria (https://www.eshonline.org). NT was defined by
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mean 24h BP levels <130/80mmHg in untreated indi-
viduals with or without isolated nocturnal HT
(120mmHg (systolic) and/or 70mmHg (diastolic))
but without isolated daytime HT (135mmHg (sys-
tolic) and/or 85mmHg (diastolic)). HT was defined
by mean 24h BP levels 130mmHg (systolic) and/or
80mmHg (diastolic) or by isolated daytime HT
(135mmHg (systolic) and/or 85mmHg (diastolic))
or in case of use of antihypertensive medications
whatever the BP levels. A subgroup analysis was per-
formed between the patients with versus without anti-
hypertensive medications. Metabolomics analyses
were conducted on stool supernatants using Nuclear
Magnetic Resonance (NMR) and the CPMG relaxation-
editing sequence with presaturation, as previously
detailed [2]. Faecal concentrations of acetate, butyrate
and propionate were obtained by integrating the sig-
nals at 1.93 ppm, 1.56 ppm and 1.05 ppm, respectively.
Univariate metabolomics data were subjected to a
Mann–Whitney test. Mann–Whitney test and Chi-
square test were used to compare continuous and cat-
egorical clinical variables, respectively.
Results
Our 44-case cohort included 13 non-dippers (29.6%)
and 31 dippers, with 35 HT (79.4%) and 9NT patients.
Ten non-dippers (28.6%) and 25 dippers were HT.
Nineteen HT patients were under anti-hypertensive
medications (43.1%), including 7 non-dippers and 12
dippers. The mean age and body mass index (BMI) of
the cohort were 50.8 ± 9.5 years and 26.3 ± 3.5 kg/m2,
respectively. No significant difference in BP values,
age, BMI, smoking habits, alcohol consumption, famil-
ial HT, personal history of diabetes, cardiovascular or
gastro-intestinal disorders was observed between
dippers and non-dippers (Table 1). The comparison of
BP levels between patients with anti-hypertensive
medications (i.e. ‘treated’) and those without any anti-
hypertensive treatment (i.e. ‘untreated’) did not show
any significant differences (Table 2). The relative quan-
tification of faecal SCFAs showed higher amounts of
acetate, butyrate and propionate in the stools of non-
dippers (n¼ 12) versus dippers (n¼ 26) (p¼ 0.0252,
p¼ 0.0468, and p¼ 0.0496, respectively; n¼ 38 in toto)
(Figure 1(A)). Multivariate statistical analyses by the
means of PCA-X model of reduced and normalised
spectral data lead to the exclusion of 5 dippers and 1
non-dipper because of uninterpretable data. The faecal
amounts of acetate, butyrate and propionate were
higher in non-dippers (n¼ 5) versus dippers (n¼ 16) in
patients without anti-hypertensive medications
(p¼ 0.0414, p¼ 0.0108, and p¼ 0.0602, respectively;
n¼ 21 in toto) (Figure 1(B)). When focussing only on
HT patients without any anti-hypertensive medica-
tions, a not significant trend for higher amounts of
the 3 main SCFAs was still found in the stools of non-
dippers (n¼ 2) versus dippers (n¼ 12) (p¼ 0.0556;
n¼ 14 in toto).
Discussion
To the best of our knowledge, the BP dipping status has
never been associated with GM composition or its
derived metabolites. The non-dipping BP pattern reflects
a disruption in the circadian BP rhythm [4,5]. Several
molecular components of the circadian timing system
controlled by the central and peripheral clocks have
been involved in metabolic abnormalities leading to
non-dipping BP profile [4]. This circadian misalignment
between clocks is not well understood. However, it may
implicate the GM [6,7]. Indeed, the relative abundance of
60% of the total gut bacteria and their metabolites
undergo circadian variations, which may be disrupted in
case of dysbiosis and/or circadian misalignment [6].
Table 1. Clinical characteristics of the cohort (dippers vs
non-dippers).
Dippers Non-dippers p Value
N 31 13
Age (years) 50.6 ± 9.9 53 ± 10.4 0.95
BMI (kg/m2) 26 ± 3.4 26.9 ± 3.8 0.39
Smokers (%, N) 16.1 % (5) 7.7 % (1) 0.46
Alcohol (glass/week) 4.9 ± 5 4.1 ± 4.3 0.78
Family HT (%, N) 42 % (13) 53.8 % (7) 0.47
Diabetes (%, N) 3.2 % (1) 0 ns
CV history (%, N) 19.3 % (6) 30.7 % (4) 0.41
GE history (%, N) 42 % (13) 46.1 % (6) 0.8
24h Systolic BP (mmHg) 131.6 ± 12.1 132.9 ± 18.7 0.96
24h Diastolic BP (mmHg) 81.5 ± 9.5 81.5 ± 13.4 0.74
24h Mean BP (mmHg) 97.6 ± 10.2 98.9 ± 13.6 0.89
Night/Day Systolic BP ratio 0.84 ± 0.04 0.96 ± 0.04 <0.0001
Anti-HT treatment (%, N) 38.8 % (12) 53.7 % (7) 0.35
BMI: body mass index; BP: blood pressure; CV: cardiovascular; GE: gastro-
enterological; HT: hypertension; ns: not significant.
Table 2. Blood pressure values between patients with anti-
hypertensive medications (treated) and without anti-hyperten-
sive medications (untreated).
Treated Untreated p Value
N 19 25
24h Systolic BP (mmHg) 134.5 ± 15.8 130.1 ± 12.8 0.37
24h Diastolic BP (mmHg) 81.8 ± 11.6 81.3 ± 10.1 0.99
24h Mean BP (mmHg) 99.5 ± 11.8 96.9 ± 10.8 0.44
Daytime Systolic BP (mmHg) 140.3 ± 16.1 136 ± 13.8 0.43
Daytime Diastolic BP (mmHg) 86.5 ± 11.9 86.8 ± 11.1 0.95
Daytime Mean BP (mmHg) 104.3 ± 12.2 101.8 ± 12.4 0.51
Night-time Systolic BP (mmHg) 123.4 ± 17.6 118.1 ± 12.5 0.37
Night-time Diastolic BP (mmHg) 72.9 ± 11.9 70.8 ± 10.5 0.72
Night-time Mean BP (mmHg) 90.3 ± 13.1 85 ± 12.4 0.21
BP: blood pressure.
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Moreover, the integrity of GM and its production of
metabolites, including the SCFAs, seem essential for the
circadian rhythmicity of gene expression in several
organs [8,9]. In both mice and humans, Thaiss et al.
showed that jetlag-induced dysbiosis promotes the
development of obesity and glucose intolerance, which
are transferrable to germ-free mice through faecal trans-
plantation [10]. On the basis of these observations, one
may speculate that disruption in the circadian BP rhythm
(i.e. the non-dipping BP profile) may be associated with
a disrupted rhythmicity of GM-mediated metabolite
secretion, including SCFAs. None of our patients pre-
sented metabolic dysfunctions or confounding factors,
when comparing dippers versus non-dippers. Although
confirmatory data in larger cohorts are obviously
needed, our observation of a putative link between GM
and stool metabolome and BP dipping may unravel
innovative pathophysiological investigations in the field.
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Figure 1. (A) Relative amounts of acetate, butyrate and propionate in the stools of non-dippers (n¼ 12) versus dippers (n¼ 26) in
the whole cohort. p< 0.05. (B) Relative amounts of acetate, butyrate and propionate in the stools of non-dippers (n¼ 5) versus
dippers (n¼ 16) in the subgroup of patients without anti-hypertensive medications (untreated patients). p< 0.05.
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